This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of Copenhagen. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Mikkel Bring Christensen: Innovator in Peptide Analogues
Introduction
Mikkel Bring Christensen is a notable inventor based in Broenshoej, Denmark. He has made significant contributions to the field of biochemistry, particularly in the development of peptide analogues that have potential therapeutic applications.
Latest Patents
Mikkel holds a patent for GIP peptide analogues. This patent, which includes the compound GIP(3-30), focuses on glucose-dependent insulinotropic polypeptide (GIP)-derived peptide analogues. These analogues are designed to act as antagonists of the GIP receptor and are intended for the treatment of disorders such as obesity, diabetes mellitus, and insulin resistance. He has 1 patent to his name.
Career Highlights
Mikkel Bring Christensen is affiliated with the University of Copenhagen, where he conducts research and develops innovative solutions in the field of peptide chemistry. His work is instrumental in advancing our understanding of metabolic disorders and their treatment.
Collaborations
Mikkel collaborates with esteemed colleagues, including Mette Marie Rosenkilde and Alexander Hovard Sparre-Ulrich. Their combined expertise enhances the research efforts at the University of Copenhagen.
Conclusion
Mikkel Bring Christensen is a prominent figure in the realm of peptide research, with a focus on developing therapeutic solutions for metabolic disorders. His contributions are paving the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile